Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials
-
* Corresponding author: Sandro B Rizoli sandro.rizoli@sw.ca
Critical Care 2006, 10:R178 doi:10.1186/cc5133